Please provide your email address to receive an email when new articles are posted on . The FDA approved denosumab-bmwo for all indications of the reference drugs Prolia and Xgeva. According to a ...

LONDON, Sept 29 (Reuters) - The same mechanism that makes Amgen's new bone drug denosumab an effective treatment for osteoporosis may also mean it could help prevent breast cancer, scientists said on ...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYV™ (denosumab ...

A 3-month course of romosozumab followed by denosumab provides similar BMD gains to those seen with 12 months of romosozumab in women with postmenopausal osteoporosis.

LONDON (Reuters) - The same mechanism that makes Amgen's new bone drug denosumab an effective treatment for osteoporosis may also mean it could help prevent breast cancer, scientists said on Wednesday ...